Clinical Trials Browser

Phase 1 × Solid Tumors × aflibercept × Clear all

NCT01688960 2015-03-17

Nesvacumab (REGN910/ SAR307746) and Aflibercept ("Ziv-aflibercept" in the U.S.) in Patients With Advanced Solid Malignancies

Phase 1 Completed

Other solid neoplasm

Solid Tumors